Inhibition of breast cancer proliferation and metastasis by strengthening host immunity with a prolonged oxygen-generating phototherapy hydrogel.
Animals
Breast Neoplasms
/ drug therapy
Cell Line, Tumor
Cell Proliferation
/ drug effects
Chlorophyllides
Female
Humans
Hydrogels
/ therapeutic use
Mice
Mice, Inbred BALB C
Mice, Nude
Oxygen
/ therapeutic use
Photochemotherapy
/ methods
Photosensitizing Agents
/ therapeutic use
Porphyrins
/ therapeutic use
Tumor Hypoxia
/ drug effects
Anti-metastasis
Hydrogel
Hypoxia alleviation
Immunotherapy
Photodynamic therapy
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
10 09 2019
10 09 2019
Historique:
received:
19
12
2018
revised:
10
07
2019
accepted:
20
07
2019
pubmed:
26
7
2019
medline:
6
10
2020
entrez:
26
7
2019
Statut:
ppublish
Résumé
Hypoxia is a potent tumor microenvironmental (TME) factor promoting immunosuppression and metastatic progression. For current anticancer therapeutic strategies, the combination of hypoxia alleviation and photodynamic therapy (PDT) might be a useful approach to further improve anticancer efficacy. In this study, we alleviated tumor hypoxia using a prolonged oxygen-generating phototherapy hydrogel (POP-Gel), which effectively elevated the oxygen level and shrank the hypoxic regions of tumors for up to 5 days evaluated by photoacoustic (PA) imaging and immunofluorescence staining, meeting the requirement of the "once injection, sustained treatment" strategy and significantly increasing PDT efficacy. The long-period improvement of the tumor hostile environment downregulated the expression of hypoxia inducible factor (HIF)-1α and vascular endothelial growth factor (VEGF), further preventing tumor growth and metastasis. More importantly, the enhanced PDT triggered a more intense immune response, improving the inhibition of triple negative breast cancer growth even tumor elimination. The POP-Gel may contribute useful insights into the combination of hypoxia alleviation and PDT.
Identifiants
pubmed: 31344426
pii: S0168-3659(19)30415-8
doi: 10.1016/j.jconrel.2019.07.028
pii:
doi:
Substances chimiques
Chlorophyllides
0
Hydrogels
0
Photosensitizing Agents
0
Porphyrins
0
phytochlorin
5S2CCF3T1Z
Oxygen
S88TT14065
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
82-93Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.